SPPL:NASDAQSIMPPLE LTD. Analysis
Data as of 2026-06-08 - not real-time
$3.78
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical snapshot: SPPL trades at $3.78, comfortably above its 20‑day (3.04) and 50‑day (2.53) SMAs and just above the 200‑day SMA (3.70), while the MACD histogram remains positive, indicating short‑term bullish momentum. However, the RSI sits at 74.4, flagging an overbought condition, and volume is on a decreasing trend, suggesting waning buying pressure. The market sentiment is unusually optimistic, with the Fear & Greed Index at “Extreme Greed.”
Fundamental backdrop: The company’s revenue growth is a modest 2.6% on a $5.9 M base, yet operating margins are –88.8% and profit margins –70.8%, reflecting deep losses. Cash flow is negative ($‑1.8 M operating, $‑3.7 M free) and the balance sheet is strained, with a debt‑to‑equity ratio over 114% and a price‑to‑book of 6.9×. These fundamentals, combined with a 30‑day volatility near 97% and a max drawdown of –72.8%, paint a picture of a highly risky, overvalued stock despite the short‑term technical upside.
Fundamental backdrop: The company’s revenue growth is a modest 2.6% on a $5.9 M base, yet operating margins are –88.8% and profit margins –70.8%, reflecting deep losses. Cash flow is negative ($‑1.8 M operating, $‑3.7 M free) and the balance sheet is strained, with a debt‑to‑equity ratio over 114% and a price‑to‑book of 6.9×. These fundamentals, combined with a 30‑day volatility near 97% and a max drawdown of –72.8%, paint a picture of a highly risky, overvalued stock despite the short‑term technical upside.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- RSI in overbought territory
- Decreasing volume trend
- Extreme market greed vs weak fundamentals
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD signal
- Price still above key moving averages
- Continued earnings losses and high leverage
Long Term
> 3 yearsCautious
Model confidence: 6/10
Key Factors
- Sustained negative cash flow
- High debt‑to‑equity ratio
- Valuation multiples far above book and sales
Key Metrics & Analysis
Financial Health
Revenue Growth2.60%
Profit Margin-70.84%
ROE-142.38%
ROA-26.25%
Debt/Equity114.57
P/B Ratio6.9
Op. Cash Flow$-1807519
Free Cash Flow$-3741815
Industry P/E30.2
Technical Analysis
TrendNeutral
RSI74.4
Support$2.45
Resistance$4.00
MA 20$3.04
MA 50$2.53
MA 200$3.70
MACDBullish
VolumeDecreasing
Fear & Greed Index83.02
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.06
Volatility96.96%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.